About Lundbeck UK
Underpinning our vision are three strategic pillars; Deliver excellent results, Deliver value to customers, Be a great place to work. The company’s products are targeted at depression and anxiety, psychotic diseases. Alzheimer’s and Parkinson’s disease.
Lundbeck UK was founded in 1972, and was initially based in Welwyn in Hertfordshire with a staff of four people. The company expanded rapidly, moving initially to larger premises in Luton and then to Milton Keynes. We subsequently moved to a premises in St Albans, where we are currently located.
Lundbeck UK markets a number of different pharmaceuticals for the treatment of brain diseases.This includes: Brintellix▼® (Depression) and Lundbeck UK also co-promotes Abilify Maintena® (schizophrenia) a product distributed by Otsuka UK.
Lundbeck currently employs around 70 people across the UK and Ireland. .
Lundbeck Global Tax Policy
Lundbecks Global tax policy is published on http://lundbeck.com/global/sustainability/society/tax-policy
This tax policy has been prepared in accordance with requirements detailed at paragraph 19(2) Schedule 19 Finance Act 2016 and is applicable to all UK incorporated entities which are headed by Lundbeck Group Limited for the financial year ending 31 December 2017.